Hansjochen Wilke

机构：Kliniken Essen-Mitte

发表论文 232 篇 · 总被引 12145 次 · h-index 47

代表论文

• Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial (2014 · The Lancet Oncology · 被引 2507)
• Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial (2017 · European Journal of Cancer · 被引 290)
• S3-Leitlinie „Magenkarzinom” - (2011 · Zeitschrift für Gastroenterologie · 被引 284)
• Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study (2010 · Annals of Oncology · 被引 116)
• RAINBOW: A global, phase III, randomized, double-blind study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in the treatment of metastatic gastroesophageal junction (GEJ) and gastric adenocarcinoma following disease progression on first-line platinum- and fluoropyrimidine-containing combination therapy rainbow IMCL CP12-0922 (I4T-IE-JVBE). (2014 · Journal of Clinical Oncology · 被引 93)
• Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer (2015 · Gastric Cancer · 被引 87)